Pioneering the Future of Healthcare: Pfizer’s AI Advantage

September 10, 2025

Artificial intelligence is a game-changing ally in the ongoing effort to bring life-changing medicines to patients. Imagine predicting the potential success of investigational therapies with unprecedented accuracy before running a single clinical study, or producing twenty thousand additional COVID-19 treatment doses per batch due to more efficient manufacturing processes. These are not theoretical use cases of the future – Pfizer is using AI technologies to do all of these, and more, today.

Our scientists have been harnessing the power of these advanced technologies since 2014, when we pioneered the use of AI to monitor drug safety. Ever since, Pfizer has consistently been an industry leader in AI adoption – and our accelerated ability to analyze data and provide insights is transforming every stage of the drug discovery, development and manufacturing process.

Let’s dive into some of the ways that Pfizer is leveraging AI today.

Forward-looking statements included herein and in the linked content, including those related to our anticipated operating and financial performance, including our financial guidance, our product and pipeline advancements, our strategic priorities, our cost realignment program and our efforts to return value to shareholders, are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.

Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.